This study tests a new device called SEAL that is placed inside a brain aneurysm to block blood flow and prevent rupture. About 279 people with either unruptured or recently ruptured aneurysms will receive the treatment. The main goal is to see if the aneurysm stays sealed after …
Phase: PHASE3 • Sponsor: Galaxy Therapeutics INC • Aim: Disease control
Last updated May 08, 2026 12:03 UTC